A Phase I, Multicenter, Open Label Study on the Effects of SNDX-275 on Expression of Biomarkers in Subjects With Newly Diagnosed Breast Cancer
Clinical trial NCT00754312 · TERMINATED
Trial details
- NCT number
- NCT00754312
- Sponsor
- Syndax Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-01
- Primary completion
- 2009-02-28
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.